JW Asset Management

What is JW Asset Management?

JW Asset Management is an investment firm based in New York, New York, established in 1997 by Jason Wild. They are registered as an SEC-registered investment adviser and manage over $1 billion in assets, with a primary focus on the healthcare sector, which includes pharmaceutical investments and expanding interests in the cannabis sector.

They are long-term growth investors with an entrepreneurial approach, emphasizing flexibility and experience, allowing them to invest effectively across both private and public equity markets. This dual-market investment capability enables them to allocate capital across a larger opportunity set, enhancing their network and industry knowledge without the traditional constraints that private equity firms might face.

Their approach is patient and focused on maximizing the value of investments over a long-term horizon. JW Asset Management prides itself on industry knowledge and relationships, regularly engaging with industry participants. They possess an extensive network of contacts within the pharmaceutical industry, granting access to unique investment opportunities and differentiated market intelligence.

By consistently meeting and connecting with industry insiders, they leverage these relationships to identify investment opportunities and market trends. They aim to partner with exceptional management teams that share their strategic vision.

Their industry experience and strong reputation have made them a valued partner for companies seeking capital. Their reputation, work ethic, and entrepreneurial spirit often afford them investment opportunities at improved valuations relative to the competition.

Jason Wild is notable for being sought out by companies for his visionary leadership and ability to contribute beyond investment through guidance and insight as a board member and trusted advisor.